Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
436.87B | 442.78B | 431.20B | 388.36B | 328.04B | 381.58B | Gross Profit |
84.11B | 81.28B | 85.25B | 78.76B | 60.31B | 71.25B | EBIT |
21.78B | 22.42B | 32.55B | 30.00B | 18.30B | -40.30B | EBITDA |
36.52B | 40.95B | 50.88B | 48.52B | 37.75B | -19.11B | Net Income Common Stockholders |
14.05B | 15.82B | 27.21B | 22.55B | 17.09B | -61.88B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
44.05B | 46.64B | 47.75B | 54.87B | 69.81B | 51.59B | Total Assets |
470.98B | 476.53B | 446.84B | 434.19B | 426.63B | 410.45B | Total Debt |
86.78B | 101.14B | 84.54B | 90.86B | 124.85B | 121.98B | Net Debt |
45.65B | 57.09B | 40.96B | 38.74B | 56.15B | 71.56B | Total Liabilities |
237.66B | 250.12B | 255.80B | 273.27B | 309.91B | 330.64B | Stockholders Equity |
223.77B | 217.19B | 182.83B | 153.41B | 110.68B | 74.09B |
Cash Flow | Free Cash Flow | ||||
8.79B | 15.25B | 12.29B | 14.95B | 9.58B | -25.67B | Operating Cash Flow |
34.65B | 39.86B | 23.91B | 24.25B | 20.83B | -5.00B | Investing Cash Flow |
-27.12B | -23.50B | -13.52B | -10.87B | -6.28B | -21.50B | Financing Cash Flow |
-18.96B | -15.03B | -20.18B | -32.71B | 1.15B | 22.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.91T | 5.70 | 12.64% | 4.07% | 6.27% | 19.66% | |
76 Outperform | €146.11B | 10.34 | 6.70% | 3.84% | -1.41% | -37.77% | |
76 Outperform | ¥34.19T | 7.29 | 13.59% | 3.44% | 6.52% | -1.27% | |
74 Outperform | $3.48T | 8.24 | 15.02% | 2.44% | 14.46% | 62.35% | |
71 Outperform | $6.82T | 7.91 | 6.54% | 4.61% | 12.25% | 15.01% | |
70 Outperform | ¥1.03T | 12.67 | 7.19% | 4.38% | 4.48% | -51.81% | |
62 Neutral | $6.84B | 11.22 | 2.83% | 3.93% | 2.65% | -21.93% |